Chambal Fertilisers and Chemicals (CHAMBLFERT) Q3 24/25 earnings summary

Executive summary

• Standalone EBITDA for Q3 was INR 843 crore, up 16% YoY; PAT was INR 505 crore, up 25% YoY; consolidated Q3 PAT was INR 534 crore, up 16% YoY; 9M PAT was INR 1,519 crore, up 29% YoY.

• Urea production and sales volumes increased YoY, with energy efficiency improving by 3% and production up by ~125 MT/day.

• Crop protection and specialty nutrients segments showed strong growth, with 26% Q3 revenue growth and 39% YoY contribution growth; 12 new products launched in 9M FY25.

• IMACID JV performed well, contributing to consolidated PAT growth and planning expansion to 7 lakh MT by 2027-28.

• CFCL-TERI partnership established a Centre of Excellence for sustainable agriculture solutions.

Financial highlights

• Q3 standalone revenue was ₹4,918 crore, up 13% YoY; 9M revenue was ₹14,197 crore.

• Q3 standalone EBITDA: INR 843 crore (16% YoY growth); PAT: INR 505 crore (25% YoY growth); 9M standalone EBITDA: INR 2,619 crore (19% YoY growth); PAT: INR 1,557 crore (25% YoY growth).

• Q3 consolidated PAT: INR 534 crore (16% YoY growth); 9M PAT: INR 1,519 crore (29% YoY growth).

• Crop protection and specialty nutrients Q3 revenue: INR 255 crore (26% YoY growth); contribution: INR 68 crore (39% YoY growth).

• Gas cost for Q3: $15.85 per MMBTU (LCV basis).

Outlook and guidance

• TAN plant expected to start commercial production in January 2026, with rapid ramp-up planned; timeline shifted due to plant configuration changes, but no cost overrun.

• IMACID phosphoric acid expansion to 7 lakh MT by 2027-28, with total investment of $173 million.

• Entry into hybrid and research variety seeds planned for Kharif FY25; focus on expanding biologicals and specialty nutrients portfolio.